BackAlx Oncology Holdings Overview

Alx Oncology Holdings Receivables

Alx Oncology Holdings's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

Alx Oncology Holdings Receivables History

Loading

Alx Oncology Holdings vs. peers: Receivables Comparison

Loading

Alx Oncology Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alx Oncology Holdings (ALXO) FAQ

Alx Oncology Holdings (ALXO) currently reports a receivables of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Alx Oncology Holdings's receivables history and peer comparisons.

Alx Oncology Holdings's receivables changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alx Oncology Holdings reported $0 in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alx Oncology Holdings, and consider following ALXO for alerts when major investors trade the stock.

Alx Oncology Holdings is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALXO with unrelated industries.